June Li

1.6k total citations
37 papers, 1.0k citations indexed

About

June Li is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, June Li has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in June Li's work include Platelet Disorders and Treatments (16 papers), Blood groups and transfusion (6 papers) and Acute Myeloid Leukemia Research (5 papers). June Li is often cited by papers focused on Platelet Disorders and Treatments (16 papers), Blood groups and transfusion (6 papers) and Acute Myeloid Leukemia Research (5 papers). June Li collaborates with scholars based in United States, Canada and China. June Li's co-authors include Heyu Ni, Conglei Li, Issaka Yougbaré, Guangheng Zhu, Pingguo Chen, John Freedman, Miao Xu, Naadiya Carrim, Li Ma and Sean Lang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

June Li

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
June Li United States 17 654 220 199 119 115 37 1.0k
Colleen Notley Canada 22 1.1k 1.7× 316 1.4× 213 1.1× 152 1.3× 162 1.4× 39 1.5k
Michael Bromberg United States 17 438 0.7× 275 1.3× 85 0.4× 206 1.7× 140 1.2× 27 930
Yasuo Hirayama Japan 15 705 1.1× 332 1.5× 260 1.3× 255 2.1× 355 3.1× 61 1.3k
Katherine Larabee United States 5 394 0.6× 476 2.2× 371 1.9× 69 0.6× 152 1.3× 6 1.2k
Yao-Qi Huang United States 15 543 0.8× 445 2.0× 158 0.8× 239 2.0× 241 2.1× 17 1.2k
Mojtaba Akhtari United States 19 444 0.7× 290 1.3× 263 1.3× 190 1.6× 394 3.4× 77 1.2k
Sabine Blum Switzerland 17 297 0.5× 420 1.9× 124 0.6× 228 1.9× 214 1.9× 59 976
Caterina Casari France 20 950 1.5× 189 0.9× 252 1.3× 164 1.4× 37 0.3× 58 1.3k
José Perdomo Australia 16 369 0.6× 711 3.2× 365 1.8× 70 0.6× 155 1.3× 39 1.4k
Seiji Kojima Japan 20 414 0.6× 308 1.4× 220 1.1× 175 1.5× 213 1.9× 40 1.1k

Countries citing papers authored by June Li

Since Specialization
Citations

This map shows the geographic impact of June Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June Li more than expected).

Fields of papers citing papers by June Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June Li. The network helps show where June Li may publish in the future.

Co-authorship network of co-authors of June Li

This figure shows the co-authorship network connecting the top 25 collaborators of June Li. A scholar is included among the top collaborators of June Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June Li. June Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamura, Manjula Kurella, Mengjiao Huang, Jaejin An, et al.. (2025). SPRINT Treatment Among Adults With Chronic Kidney Disease From 2 Large Health Care Systems. JAMA Network Open. 8(1). e2453458–e2453458. 3 indexed citations
2.
Li, June, Wenjing Ma, Xiaobo Wu, et al.. (2025). Kupffer cells are essential for platelet-mediated thrombopoietin generation in the liver. Proceedings of the National Academy of Sciences. 122(38). e2517319122–e2517319122. 2 indexed citations
3.
Charu, Vivek, Glenn M. Chertow, June Li, et al.. (2023). Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. Journal of the American Society of Nephrology. 35(2). 216–228. 3 indexed citations
4.
Shi, Yaoyao, et al.. (2021). Next-Generation Immunotherapies to Improve Anticancer Immunity. Frontiers in Pharmacology. 11. 566401–566401. 13 indexed citations
5.
Hauser, Robert A., Nobutaka Hattori, Hubert H. Fernandez, et al.. (2021). Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. Journal of Parkinson s Disease. 11(4). 1663–1675. 26 indexed citations
6.
Shen, Chuanbin, Ming Liu, Pingguo Chen, et al.. (2021). Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia. Archives of Toxicology. 95(11). 3589–3599. 7 indexed citations
7.
Li, June, et al.. (2021). Novel Mechanisms of Thrombopoietin Generation: The Essential Role of Kupffer Cells. Blood. 138(Supplement 1). 3139–3139. 2 indexed citations
8.
Li, Conglei, June Li, & Heyu Ni. (2020). Crosstalk Between Platelets and Microbial Pathogens. Frontiers in Immunology. 11. 1962–1962. 64 indexed citations
9.
Shen, Chuanbin, Ming Liu, Wang Gan, et al.. (2020). The 14-3-3ζ–c-Src–integrin-β3 complex is vital for platelet activation. Blood. 136(8). 974–988. 33 indexed citations
10.
Leung, Jenny, Andrew Ho, Risa Ozaki, et al.. (2019). Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus. Hong Kong Medical Journal. 25(4). 312–319. 1 indexed citations
11.
Xu, Miao, June Li, Miguel A. D. Neves, et al.. (2018). GPIbα is required for platelet-mediated hepatic thrombopoietin generation. Blood. 132(6). 622–634. 50 indexed citations
12.
Li, June, Dianne E. van der Wal, Guangheng Zhu, et al.. (2015). Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nature Communications. 6(1). 7737–7737. 260 indexed citations
13.
Cogle, Christopher R., Najmaldin Saki, Elahe Khodadi, et al.. (2015). Bone marrow niche in the myelodysplastic syndromes. Leukemia Research. 39(10). 1020–1027. 54 indexed citations
14.
Vadasz, Brian, Pingguo Chen, Issaka Yougbaré, et al.. (2015). Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. Genes & Diseases. 2(2). 173–185. 20 indexed citations
15.
Li, June, et al.. (2014). Inhibition of Sp1 Functions by Its Sequestration into PML Nuclear Bodies. PLoS ONE. 9(4). e94450–e94450. 12 indexed citations
16.
Li, June, Dianne E. van der Wal, Lingyan Zhu, et al.. (2013). Fc-independent Phagocytosis: Implications for IVIG and other Therapies in Immune-mediated Thrombocytopenia. Cardiovascular & Haematological Disorders - Drug Targets. 13(1). 50–58. 14 indexed citations
17.
Wang, Xiaodong, et al.. (2013). [Clinical research of timing of application of antibiotics in septic shock of pediatric patients].. PubMed. 25(4). 207–10. 2 indexed citations
18.
Zhao, Shan, et al.. (2012). Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells. Oncology Reports. 28(4). 1399–1405. 19 indexed citations
19.
Li, June. (2011). Quiescence regulators for hematopoietic stem cell. Experimental Hematology. 39(5). 511–520. 59 indexed citations
20.
Li, June, et al.. (2006). Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem/Progenitor Cells. Journal of Biological Chemistry. 281(24). 16536–16545. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026